Market Research Logo

Inflammatory Bowel Disease - Pipeline Review, H1 2015

Inflammatory Bowel Disease - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Inflammatory Bowel Disease and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Inflammatory Bowel Disease
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Inflammatory Bowel Disease and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Inflammatory Bowel Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Inflammatory Bowel Disease pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Inflammatory Bowel Disease
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Inflammatory Bowel Disease pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Inflammatory Bowel Disease Overview
Therapeutics Development
Inflammatory Bowel Disease - Therapeutics under Development by Companies
Inflammatory Bowel Disease - Therapeutics under Investigation by Universities/Institutes
Inflammatory Bowel Disease - Pipeline Products Glance
Inflammatory Bowel Disease - Products under Development by Companies
Inflammatory Bowel Disease - Products under Investigation by Universities/Institutes
Inflammatory Bowel Disease - Companies Involved in Therapeutics Development
Inflammatory Bowel Disease - Therapeutics Assessment
Drug Profiles
Inflammatory Bowel Disease - Recent Pipeline Updates
Inflammatory Bowel Disease - Dormant Projects
Inflammatory Bowel Disease - Discontinued Products
Inflammatory Bowel Disease - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for Inflammatory Bowel Disease, H1 2015
Number of Products under Development for Inflammatory Bowel Disease - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Development by Companies, H1 2015 (Contd..5)
Number of Products under Development by Companies, H1 2015 (Contd..6)
Number of Products under Development by Companies, H1 2015 (Contd..7)
Number of Products under Development by Companies, H1 2015 (Contd..8)
Number of Products under Development by Companies, H1 2015 (Contd..9)
Number of Products under Development by Companies, H1 2015 (Contd..10)
Number of Products under Development by Companies, H1 2015 (Contd..11)
Number of Products under Investigation by Universities/Institutes, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Development by Companies, H1 2015 (Contd..8)
Products under Development by Companies, H1 2015 (Contd..9)
Products under Development by Companies, H1 2015 (Contd..10)
Products under Development by Companies, H1 2015 (Contd..11)
Products under Development by Companies, H1 2015 (Contd..12)
Products under Development by Companies, H1 2015 (Contd..13)
Products under Development by Companies, H1 2015 (Contd..14)
Products under Development by Companies, H1 2015 (Contd..15)
Products under Development by Companies, H1 2015 (Contd..16)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Inflammatory Bowel Disease - Pipeline by 4SC AG, H1 2015
Inflammatory Bowel Disease - Pipeline by AB Science, H1 2015
Inflammatory Bowel Disease - Pipeline by AbbVie Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Advinus Therapeutics Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by Aerpio Therapeutics, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Alba Therapeutics Corporation, H1 2015
Inflammatory Bowel Disease - Pipeline by AlbireoPharma, H1 2015
Inflammatory Bowel Disease - Pipeline by Alfa Wassermann S.p.A, H1 2015
Inflammatory Bowel Disease - Pipeline by Allozyne, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Altheus Therapeutics, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Alvine Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Am-Pharma B.V., H1 2015
Inflammatory Bowel Disease - Pipeline by Amakem NV, H1 2015
Inflammatory Bowel Disease - Pipeline by Amgen Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Amorepacific Corporation, H1 2015
Inflammatory Bowel Disease - Pipeline by Ampio Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Apogee Biotechnology Corporation, H1 2015
Inflammatory Bowel Disease - Pipeline by Ardelyx, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Arena Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Argos Therapeutics, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by ASKA Pharmaceutical Co., Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by AstraZeneca Plc, H1 2015
Inflammatory Bowel Disease - Pipeline by Avaxia Biologics, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Axxam SpA, H1 2015
Inflammatory Bowel Disease - Pipeline by Basilea Pharmaceutica AG, H1 2015
Inflammatory Bowel Disease - Pipeline by BIOCAD, H1 2015
Inflammatory Bowel Disease - Pipeline by BioLineRx, Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by Biotec Pharmacon ASA, H1 2015
Inflammatory Bowel Disease - Pipeline by BioTherapeutics Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Blueberry Therapeutics Ltd, H1 2015
Inflammatory Bowel Disease - Pipeline by Boehringer Ingelheim GmbH, H1 2015
Inflammatory Bowel Disease - Pipeline by Bristol-Myers Squibb Company, H1 2015
Inflammatory Bowel Disease - Pipeline by Calypso Biotech SA, H1 2015
Inflammatory Bowel Disease - Pipeline by Catabasis Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Celgene Corporation, H1 2015
Inflammatory Bowel Disease - Pipeline by Celltrion, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Celsus Therapeutics Plc, H1 2015
Inflammatory Bowel Disease - Pipeline by ChemoCentryx, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by ChironWells GmbH, H1 2015
Inflammatory Bowel Disease - Pipeline by CLL Pharma, H1 2015
Inflammatory Bowel Disease - Pipeline by Cosmo Pharmaceuticals S.p.A, H1 2015
Inflammatory Bowel Disease - Pipeline by Creabilis SA, H1 2015
Inflammatory Bowel Disease - Pipeline by Daiichi Sankyo Company, Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by DBV Technologies S.A., H1 2015
Inflammatory Bowel Disease - Pipeline by Delenex Therapeutics AG, H1 2015
Inflammatory Bowel Disease - Pipeline by Dr. Falk Pharma GmbH, H1 2015
Inflammatory Bowel Disease - Pipeline by Effimune SAS, H1 2015
Inflammatory Bowel Disease - Pipeline by Eisai Co., Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by Eli Lilly and Company, H1 2015
Inflammatory Bowel Disease - Pipeline by Emergent BioSolutions Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Enlivex Therapeutics Ltd, H1 2015
Inflammatory Bowel Disease - Pipeline by Enzo Biochem, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Epirus Biopharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Farmacija d.o.o. Tuzla, H1 2015
Inflammatory Bowel Disease - Pipeline by Ferring International Center S.A., H1 2015
Inflammatory Bowel Disease - Pipeline by FibroGen, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Galapagos NV, H1 2015
Inflammatory Bowel Disease - Pipeline by Genentech, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Genfit SA, H1 2015
Inflammatory Bowel Disease - Pipeline by Genor BioPharma Co., Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by Gilead Sciences, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by GlaxoSmithKline Plc, H1 2015
Inflammatory Bowel Disease - Pipeline by GlycoMar Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by iCo Therapeutics Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Idera Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Immune Response BioPharma, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by ImmusanT, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Inbiopro Solutions Pvt. Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by Innovent Biologics, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Intrexon Corporation, H1 2015
Inflammatory Bowel Disease - Pipeline by Jenrin Discovery, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Johnson & Johnson, H1 2015
Inflammatory Bowel Disease - Pipeline by Kineta, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Kymab Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by Kyorin Pharmaceutical Co., Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by Kytogenics Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Lead Pharma Holding B.V., H1 2015
Inflammatory Bowel Disease - Pipeline by Lpath, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Lycera Corp., H1 2015
Inflammatory Bowel Disease - Pipeline by Mabion SA, H1 2015
Inflammatory Bowel Disease - Pipeline by Medgenics Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Mesoblast Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015
Inflammatory Bowel Disease - Pipeline by Momenta Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Neovacs SA, H1 2015
Inflammatory Bowel Disease - Pipeline by Nivalis Therapeutics, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Novozymes A/S, H1 2015
Inflammatory Bowel Disease - Pipeline by Omni Bio Pharmaceutical Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Oncobiologics, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Oncodesign SA, H1 2015
Inflammatory Bowel Disease - Pipeline by Ono Pharmaceutical Co., Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by Onyx Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Opsona Therapeutics Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by Pepscan Therapeutics, H1 2015
Inflammatory Bowel Disease - Pipeline by Pfenex Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Pfizer Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Pieris AG, H1 2015
Inflammatory Bowel Disease - Pipeline by Plexxikon Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Pluristem Therapeutics Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by ProtAb Ltd, H1 2015
Inflammatory Bowel Disease - Pipeline by Protagonist Therapeutics Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Protalix BioTherapeutics, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Provid Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Qu Biologics Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Receptos, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by RedHill Biopharma Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by ReveraGen BioPharma, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Salix Pharmaceuticals Ltd., H1 2015
Inflammatory Bowel Disease - Pipeline by Sandoz International GmbH, H1 2015
Inflammatory Bowel Disease - Pipeline by Saniona AB, H1 2015
Inflammatory Bowel Disease - Pipeline by Sareum Holdings Plc, H1 2015
Inflammatory Bowel Disease - Pipeline by Selecta Biosciences, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Selexys Pharmaceuticals Corporation, H1 2015
Inflammatory Bowel Disease - Pipeline by Sigmoid Pharma Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by Sitari Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Soligenix, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Spherium Biomed S.L., H1 2015
Inflammatory Bowel Disease - Pipeline by Stelic Institute & Co., H1 2015
Inflammatory Bowel Disease - Pipeline by Sucampo Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Swecure AB, H1 2015
Inflammatory Bowel Disease - Pipeline by Sylentis S.A., H1 2015
Inflammatory Bowel Disease - Pipeline by Synovo GmbH, H1 2015
Inflammatory Bowel Disease - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by Teva Pharmaceutical Industries Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by Tiziana Life Sciences Plc, H1 2015
Inflammatory Bowel Disease - Pipeline by Tolerys SA, H1 2015
Inflammatory Bowel Disease - Pipeline by Toray Industries, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Torrent Pharmaceuticals Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by Trino Therapeutics Limited, H1 2015
Inflammatory Bowel Disease - Pipeline by Upsher-Smith Laboratories, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Ventria Bioscience, H1 2015
Inflammatory Bowel Disease - Pipeline by VG Life Sciences, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Virobay Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Winston Pharmaceuticals, Inc., H1 2015
Inflammatory Bowel Disease - Pipeline by Zedira GmbH, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Inflammatory Bowel Disease Therapeutics - Recent Pipeline Updates, H1 2015
Inflammatory Bowel Disease - Dormant Projects, H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..1), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..2), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..3), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..4), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..5), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..6), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..7), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..8), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..9), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..10), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..11), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..12), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..13), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..14), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..15), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..16), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..17), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..18), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..19), H1 2015
Inflammatory Bowel Disease - Dormant Projects (Contd..20), H1 2015
Inflammatory Bowel Disease - Discontinued Products, H1 2015
Inflammatory Bowel Disease - Discontinued Products (Contd..1), H1 2015
Inflammatory Bowel Disease - Discontinued Products (Contd..2), H1 2015
List of Figures
Number of Products under Development for Inflammatory Bowel Disease, H1 2015
Number of Products under Development for Inflammatory Bowel Disease - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report